期刊文献+

AGAP2-AS1对结肠癌细胞增殖、凋亡的影响

Effects of AGAP2-AS1 on proliferation and apoptosis of colon cancer cells
下载PDF
导出
摘要 目的探究AGAP2-AS1在结肠癌组织中的表达及对结肠癌细胞增殖、凋亡的影响。方法从美国TCGA(The Cancer Genome Atlas)数据库结直肠数据下载结肠癌患者的RNA-Seq数据。通过TCGA数据库获得356例结直肠癌,145例健康样本,通过定量实时PCR(Polymerase Chain Reaction)检测结直肠癌细胞和正常肠黏膜上皮细胞AGAP2-AS1表达水平。用siRNA(Small interfering RNA)抑制结直肠癌细胞中AGAP2-AS1的表达,再次分析其细胞增殖、凋亡的改变。结果AGAP2-AS1在结肠癌组织和细胞中表达均显著增加。抑制AGAP2-AS1后肿瘤细胞增殖能力显著降低,凋亡显著增加(P<0.05)。结论AGAP2-AS1在结肠癌细胞系中高表达,抑制AGAP2-AS1表达可抑制结肠癌细胞增殖,并诱导其凋亡。 Objective To investigate the expression of AGAP2-AS1 in colon cancer and its effect on the proliferation and apoptosis of colon cancer cells.Methods The colorectal cancer RNA-Seq data were downloaded from The Cancer Genome Atlas(TCGA)database.A total of 356 cases of colorectal cancer and 145 healthy samples were obtained from TCGA.The expression of AGAP2-AS1 in colorectal cancer cells and normal intestinal epithelial cells was detected by quantitative real-time polymerase chain reaction(PCR).Small interfering RNA(siRNA)was used to inhibit the expression of AGAP2-AS1 in colorectal cancer cells,and the changes of its proliferation and apoptosis were further analyzed.Results The expression of AGAP2-AS1 was significantly increased in colon cancer tissues and cells.After AGAP2-AS1 was inhibited,the proliferation of tumor cells was significantly reduced and apoptosis was significantly increased(P<0.05).Conclusion AGAP2-AS1 is highly expressed in colon cancer cell lines.Inhibition of AGAP2-AS1 expression can inhibit the proliferation of colon cancer cells and induce their apoptosis.
作者 何刘 吴深宝 HE Liu;WU Shenbao(Department of Gastroenterology,Yiwu Central Hospital in Zhejiang Province,Yiwu322000,China)
出处 《中国现代医生》 2020年第23期20-23,共4页 China Modern Doctor
基金 浙江省科技计划项目(2017C33179)。
关键词 结肠癌 AGAP2-AS1 增殖 凋亡 Colon cancer AGAP2-AS1 Proliferation Apoptosis
  • 相关文献

参考文献2

二级参考文献15

  • 1王晓毓,白娟,郑玲,伍健蓉.伊立替康联合氟尿嘧啶二线治疗晚期结直肠癌观察[J].现代临床医学,2011,37(5):352-353. 被引量:5
  • 2杨玲,李连弟,陈育德,D.M.Parkin.中国2000年及2005年恶性肿瘤发病死亡的估计与预测[J].中国卫生统计,2005,22(4):218-221. 被引量:336
  • 3Siegel R , Ward E, Brawley 0, et al. Cancer statistics, 2011 : The impact of eliminating socioeconomic and racial disparities on premature cancer deaths [J] . CA Cancer J Clin, 20 11 ,61 ( 4) : 212 - 236.
  • 4MOllwaki T, Bando H, Takashima A, et al. Bevacizumab in combination with irinotecan,5 - fluorouracil,and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin - containing regimens: a multicenter ohser- vational cohort study (TCTG 2nd - BV study) [J] . Med Oncol , 2012,29(4) :2842 -2848.
  • 5Kochi M, Akiyama Y, Aoki T, et al. FOLFIRI plus bevacizumab as a first - line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC - 03 multicenter phase II study [J] . Cancer Chemother Pharmacol , 20 13 ,72 ( 5) : 1097 - 1102.
  • 6Kim JY ,Bae BN, Kwon JE, et al. Prognostic significance of epidermal growth factor receptor and Vascular endothelial growth factor receptor in colorectal adenocarcinomaf L] . APMIS,2011 ,119(7): 449 -459.
  • 7Ravikumar C, Crasta JA. Vascular endothelial growth factor expression in ovarian serous carcinomas and its effect on tumor proliferation[J] . South Asian J Cancer ,2013 ,2( 2) :87 - 90.
  • 8Ucvet A, Kul C. Cursoy S, et al. Prognostic value of epithelial growth factor receptor, vascular endothelial growth factor, E-cad- herin ,and p120 catenin in resected non - small cell lung carcinoma[J] . Arch Bronconeumol,2011 ,47 (8) :397 -402.
  • 9Naik E, O'Reilly LA, Asselin-Labat ML,et al. Destruction of tumor vasculature and abated tumor growth upon VECF blockade is driven by proapoptotic protein Bim in endothelial cells [J] . J Exp Med,2011 ,208(7) :1351 -1358.
  • 10An SJ ,Huang YS,Chen ZH,et al. Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non - small cell lung cancer treated with bevacizumab plus chemotherapyj L] . Med Oncol,2012,29(2) :627 -632.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部